Correlation Between Krebs Biochemicals and JB Chemicals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Krebs Biochemicals and JB Chemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krebs Biochemicals and JB Chemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Krebs Biochemicals and and JB Chemicals Pharmaceuticals, you can compare the effects of market volatilities on Krebs Biochemicals and JB Chemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krebs Biochemicals with a short position of JB Chemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krebs Biochemicals and JB Chemicals.

Diversification Opportunities for Krebs Biochemicals and JB Chemicals

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Krebs and JBCHEPHARM is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Krebs Biochemicals and and JB Chemicals Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on JB Chemicals Pharmac and Krebs Biochemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krebs Biochemicals and are associated (or correlated) with JB Chemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of JB Chemicals Pharmac has no effect on the direction of Krebs Biochemicals i.e., Krebs Biochemicals and JB Chemicals go up and down completely randomly.

Pair Corralation between Krebs Biochemicals and JB Chemicals

Assuming the 90 days trading horizon Krebs Biochemicals is expected to generate 4.83 times less return on investment than JB Chemicals. But when comparing it to its historical volatility, Krebs Biochemicals and is 2.1 times less risky than JB Chemicals. It trades about 0.02 of its potential returns per unit of risk. JB Chemicals Pharmaceuticals is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  98,116  in JB Chemicals Pharmaceuticals on October 27, 2024 and sell it today you would earn a total of  79,879  from holding JB Chemicals Pharmaceuticals or generate 81.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Krebs Biochemicals and  vs.  JB Chemicals Pharmaceuticals

 Performance 
       Timeline  
Krebs Biochemicals and 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.
JB Chemicals Pharmac 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days JB Chemicals Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, JB Chemicals is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Krebs Biochemicals and JB Chemicals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Krebs Biochemicals and JB Chemicals

The main advantage of trading using opposite Krebs Biochemicals and JB Chemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krebs Biochemicals position performs unexpectedly, JB Chemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in JB Chemicals will offset losses from the drop in JB Chemicals' long position.
The idea behind Krebs Biochemicals and and JB Chemicals Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.